Coronary Artery Disease(CAD): Clinical Trials

2 trials for Coronary Artery Disease(CAD), newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 unknown. 2 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 42Unknown 2

Follow Coronary Artery Disease(CAD): new trials by email Literature Review of Coronary Artery Disease(CAD) trials Research Report on Coronary Artery Disease(CAD)

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Curative Effect Evaluation of Shexiang Baoxin Pill on Coronary Artery Disease Not Amenable to Revascularization
Shexiang Baoxin pill, SBP placebo, Aspirin Enteric-coated Tablets - Coronary Artery Disease(CAD)
Phase 4UnknownJun Li4402017-06-012017-04-04
Curative Effect Evaluation of Danlou Tablet on Coronary Artery Disease Not Amenable to Revascularization
Danlou Tablet, DanLou Tablet placebo, Aspirin Enteric-coated Tablets - Coronary Artery Disease(CAD)
Phase 4UnknownJun Li4402017-06-012017-04-04

Narrower conditions

Coronary Artery Disease (2)

Broader conditions

Arterial Occlusive Diseases (2)  ·  Arteriosclerosis (2)  ·  Cardiovascular Diseases (2)  ·  Coronary Disease (2)  ·  Heart Diseases (2)  ·  Myocardial Ischemia (2)  ·  Vascular Diseases (2)

Interventions

Atorvastatin (2)  ·  Clopidogrel (2)  ·  Metoprolol (2)  ·  Tablets (2)  ·  Trimetazidine (2)  ·  isosorbide-5-mononitrate (2)  ·  danlou tablet (1)  ·  shexiang baoxin (1)

Sponsors

Jun Li (2)

Top investigators

Jie Wang, MD (2)

Results publications

PMID 20432394, PMID 20531008, PMID 20681275, PMID 22019563, PMID 23303884, PMID 27480425, PMID 27847338, PMID 23173251, PMID 26142341, PMID 27491230, PMID 29444778